Proteasome inhibitors stimulate both bone formation and hair growth by similar mechanisms

Annals of the New York Academy of Sciences

Volumn 1117, Issue , 2007, Pages 298-301

  Mundy, Gregory R ^a   Gutierrez, Gloria ^a   Garrett, Ross ^b   Gallwitz, Wolfgang ^b   Rossini, Gianni ^b   Christiansen, Claus ^c   Langenberg, Andria ^d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b OsteoScreen   (United States)

^c CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^d Neosil Inc   (United States)

Author keywords

Anagen; Bone formation; Bone morphogenetic protein; Hair follicle; Proteasome inhibitors

Indexed keywords

BONE MORPHOGENETIC PROTEIN; PROTEASOME INHIBITOR; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

BONE DEVELOPMENT; BONE REMODELING; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; HAIR GROWTH; HAVERSIAN CANAL; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; REGENERATION; REGULATORY MECHANISM;

ERINACEIDAE; MAMMALIA; MURINAE;

EID: 36549010049     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.077     Document Type: Conference Paper

References (6)

1. MUNDY, G.R. et al. 1999. Stimulation of bones formation in vitro and in rodents by statins. Science 286: 1946-1949.
2. GARRETT, I.R. et al. 2003. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J. Clin. Invest. 111: 1771-1782.
3. ZANGARI, M. et al. 2005. Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma. Br. J. Haematol. 131: 71-73.
4. LESLIE, K.S. et al. 2006. Alopecia universalis treated with bone morphogenetic protein? Br. J. Dermatol. 154: 190-191.
5. VAN NESTE, M.D. 2002. Assessment of hair loss: clinical relevance of hair growth evaluation methods. Clin. Exp. Dermatol. 27: 358-365.
6. VAN NESTE, D., T. LEROY & E. SANDRAPS. 2003. Validation and clinical relevance of a novel scalp coverage scoring method. Skin Res. Technol. 9: 64-72.